CAC
BIOX.WS

Cowen and Company’s Bioceres Crop Solutions Corp Warrants, exercisable for ordinary shares BIOX.WS Stock Holding History

Cowen and Company’s Portfolio BIOX.WS Stock Details BIOX.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-22,981
Closed -$4K – 601
2019
Q4 		$4K Sell
22,981
-86,537
-79% -$26.7K ﹤0.01% 420
2019
Q3 		$37K Buy
+109,518
New +$41.5K 0.01% 345

Other funds holding BIOX.WS

BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
SRCM
Sage Rock Capital Management New York $22.3M AUM 4.09% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
VAS
VR Advisory Services Camana Bay, Grand Cayman, Cayman Islands $845M AUM 22.79% 1-Year Est. Return

Cowen and Company's BIOX.WS Position: Q1 2020 in Review

Cowen and Company sold out of Bioceres Crop Solutions Corp Warrants, exercisable for ordinary shares (BIOX.WS) in Q1 2020, closing a stake of 22,981 shares — an estimated $4K sold.

Cowen and Company first reported a position in BIOX.WS in Q3 2019 and held it in 2 quarters. The position peaked at $37K in Q3 2019. 14 funds tracked by Wall St. Rank hold BIOX.WS as of Q1 2020.

  • Cowen and Company reported no remaining Bioceres Crop Solutions Corp Warrants, exercisable for ordinary shares position as of Q1 2020 after selling out during the quarter.
  • Cowen and Company sold 22,981 Bioceres Crop Solutions Corp Warrants, exercisable for ordinary shares shares in Q1 2020, an estimated $4K.
  • Cowen and Company first reported a position in Bioceres Crop Solutions Corp Warrants, exercisable for ordinary shares in Q3 2019 and held it in 2 quarters.
  • Cowen and Company's Bioceres Crop Solutions Corp Warrants, exercisable for ordinary shares position peaked at $37K in Q3 2019.
  • 14 funds tracked by Wall St. Rank held Bioceres Crop Solutions Corp Warrants, exercisable for ordinary shares as of Q1 2020.

Based on Cowen and Company's 13F filing for Q1 2020, filed 11 May 2020.